How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

67,024 results for

Mortality Statistics

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1. The gap between cause-of-death statistics and Household Registration reports in Shandong, China during 2011-2013: Evaluation and adjustment for underreporting in the mortality data for 262 subcounty level populations. Full Text available with Trip Pro

The gap between cause-of-death statistics and Household Registration reports in Shandong, China during 2011-2013: Evaluation and adjustment for underreporting in the mortality data for 262 subcounty level populations. Underreporting is a quality concern in mortality statistics. The purpose of this study was to assess and adjust underreporting in the population-based cause-of-death statistics. The total population (96 million) in Shandong, China was divided into 262 subcounty level populations (...) geographically and by residence type (urban/rural). For each subpopulation, the total number of deaths during the years 2011-2013 was determined using data from the Household Registration System (HRS), and was used as a reference to assess the underreporting rate (UR) in the cause-of-death data from the Shandong Death Registration System (SDRS). It was estimated that 454,615 deaths, or 21.5% (95% CI: 21.4-21.5%) were unreported. Underreporting was more pronounced in rural (22.1%) versus urban communities

2018 PLoS ONE

2. Changes in midlife death rates across racial and ethnic groups in the United States: systematic analysis of vital statistics. Full Text available with Trip Pro

Changes in midlife death rates across racial and ethnic groups in the United States: systematic analysis of vital statistics. To systematically compare midlife mortality patterns in the United States across racial and ethnic groups during 1999-2016, documenting causes of death and their relative contribution to excess deaths.Trend analysis of US vital statistics among racial and ethnic groups.United States, 1999-2016.US adults aged 25-64 years (midlife).Absolute changes in mortality measured (...) as average year-to-year change during 1999-2016 and 2012-16; excess deaths attributable to increasing mortality; and relative changes in mortality measured as relative difference between mortality in 1999 versus 2016 and the nadir year versus 2016, and the slope of modeled mortality trends for 1999-2016 and for intervals between joinpoints.During 1999-2016, all cause mortality in midlife increased not only among non-Hispanic (NH) whites but also among NH American Indians and Alaskan Natives. Although all

2018 BMJ

3. Development of a statistical model for cervical cancer cell death with irreversible electroporation in vitro. Full Text available with Trip Pro

Development of a statistical model for cervical cancer cell death with irreversible electroporation in vitro. The aim of this study was to develop a statistical model for cell death by irreversible electroporation (IRE) and to show that the statistic model is more accurate than the electric field threshold model in the literature using cervical cancer cells in vitro.HeLa cell line was cultured and treated with different IRE protocols in order to obtain data for modeling the statistical (...) relationship between the cell death and pulse-setting parameters. In total, 340 in vitro experiments were performed with a commercial IRE pulse system, including a pulse generator and an electric cuvette. Trypan blue staining technique was used to evaluate cell death after 4 hours of incubation following IRE treatment. Peleg-Fermi model was used in the study to build the statistical relationship using the cell viability data obtained from the in vitro experiments. A finite element model of IRE

2018 PLoS ONE

4. Comparing causes of death of Hodgkin lymphoma and breast cancer patients between medical records and cause-of-death statistics Full Text available with Trip Pro

) or breast cancer (BC).Two hospital-based cohorts comprising 1,215 HL patients who died in the period 1980-2013 and 714 BC patients who died in the period 2000-2013 were linked with cause-of-death statistics files. The level of agreement was assessed for common underlying causes of death using Cohen's kappa, and original death certificates were reviewed when CODDC and CODMR showed discrepancies. We examined the influence of using CODDC or CODMR on standardized mortality ratio (SMR) estimates.Agreement (...) Comparing causes of death of Hodgkin lymphoma and breast cancer patients between medical records and cause-of-death statistics Obtaining accurate data about causes of death may be difficult in patients with a complicated disease history, including cancer survivors. This study compared causes of death derived from medical records (CODMR) with causes of death derived from death certificates (CODDC) as processed by Statistics Netherlands of patients primarily treated for Hodgkin lymphoma (HL

2018 Clinical epidemiology

5. Trends in cause-specific mortality among adults with and without diagnosed diabetes in the USA: an epidemiological analysis of linked national survey and vital statistics data. Full Text available with Trip Pro

Trends in cause-specific mortality among adults with and without diagnosed diabetes in the USA: an epidemiological analysis of linked national survey and vital statistics data. Large reductions in diabetes complications have altered diabetes-related morbidity in the USA. It is unclear whether similar trends have occurred in causes of death.Using data from the National Health Interview Survey Linked Mortality files from 1985 to 2015, we estimated age-specific death rates and proportional (...) mortality from all causes, vascular causes, cancers, and non-vascular, non-cancer causes among US adults by diabetes status.From 1988-94, to 2010-15, all-cause death rates declined by 20% every 10 years among US adults with diabetes (from 23·1 [95% CI 20·1-26·0] to 15·2 [14·6-15·8] per 1000 person-years), while death from vascular causes decreased 32% every 10 years (from 11·0 [9·2-12·2] to 5·2 [4·8-5·6] per 1000 person-years), deaths from cancers decreased 16% every 10 years (from 4·4 [3·2-5·5] to 3·0

2018 Lancet

6. QuickStats: Age-Adjusted Death Rates* for Lung Cancer,† by Urbanization of County of Residence§ — National Vital Statistics System, United States, 2006 and 2016 Full Text available with Trip Pro

QuickStats: Age-Adjusted Death Rates* for Lung Cancer,† by Urbanization of County of Residence§ — National Vital Statistics System, United States, 2006 and 2016 30212444 2018 12 14 2018 12 14 1545-861X 67 36 2018 Sep 14 MMWR. Morbidity and mortality weekly report MMWR Morb. Mortal. Wkly. Rep. QuickStats: Age-Adjusted Death Rates* for Lung Cancer, † by Urbanization of County of Residence § - National Vital Statistics System, United States, 2006 and 2016. 1022 10.15585/mmwr.mm6736a8 eng (...) Journal Article 2018 09 14 United States MMWR Morb Mortal Wkly Rep 7802429 0149-2195 2018 9 14 6 0 2018 9 14 6 0 2018 9 14 6 1 epublish 30212444 10.15585/mmwr.mm6736a8 PMC6146949

2018 Morbidity and Mortality Weekly Report

7. QuickStats: Age-Adjusted Death Rates from Unintentional Falls Among Adults Aged ≥65 Years, by Sex — National Vital Statistics System, 1999–2016 Full Text available with Trip Pro

QuickStats: Age-Adjusted Death Rates from Unintentional Falls Among Adults Aged ≥65 Years, by Sex — National Vital Statistics System, 1999–2016 30260945 2018 12 14 2018 12 14 1545-861X 67 38 2018 Sep 28 MMWR. Morbidity and mortality weekly report MMWR Morb. Mortal. Wkly. Rep. QuickStats: Age-Adjusted Death Rates* from Unintentional Falls † Among Adults Aged ≥65 Years, by Sex - National Vital Statistics System, 1999-2016. 1079 10.15585/mmwr.mm6738a9 eng Journal Article 2018 09 28 United (...) States MMWR Morb Mortal Wkly Rep 7802429 0149-2195 2018 9 28 6 0 2018 9 28 6 0 2018 9 28 6 1 epublish 30260945 10.15585/mmwr.mm6738a9 PMC6188127

2018 Morbidity and Mortality Weekly Report

8. QuickStats: Age-Adjusted Death Rates from Lung Cancer,† by Race/Ethnicity — National Vital Statistics System, United States, 2001–2016 Full Text available with Trip Pro

QuickStats: Age-Adjusted Death Rates from Lung Cancer,† by Race/Ethnicity — National Vital Statistics System, United States, 2001–2016 30070984 2018 12 13 2018 12 13 1545-861X 67 30 2018 Aug 03 MMWR. Morbidity and mortality weekly report MMWR Morb. Mortal. Wkly. Rep. QuickStats: Age-Adjusted Death Rates* from Lung Cancer, † by Race/Ethnicity - National Vital Statistics System, United States, 2001-2016. 840 10.15585/mmwr.mm6730a8 eng Journal Article 2018 08 03 United States MMWR Morb (...) Mortal Wkly Rep 7802429 0149-2195 2018 8 3 6 0 2018 8 3 6 0 2018 8 3 6 1 epublish 30070984 10.15585/mmwr.mm6730a8 PMC6072057

2018 Morbidity and Mortality Weekly Report

9. Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2015 Full Text available with Trip Pro

Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2015 This study presents the 2015 nationwide cancer statistics in Korea, including the incidence, survival, prevalence, and mortality.Cancer incidence data from 1999 to 2015 was obtained from the Korea National Cancer Incidence Database and followed until December 31, 2016. Mortality data from 1983 to 2015 were obtained from Statistics Korea. The prevalence was defined as the number of cancer patients alive on January (...) 1, 2016, among all cancer patients diagnosed since 1999. Crude and age-standardized rates (ASRs) for incidence, mortality and prevalence and 5-year relative survivals were also calculated.Herein, 214,701 and 76,855 Koreans were newly diagnosed and died from cancer in 2015, respectively. The ASRs for cancer incidence and mortality in 2015 were 258.9 and 82.0 per 100,000, respectively. The overall cancer incidence rate has increased significantly by 3.4% annually from 1999 to 2012, and started

2018 Cancer research and treatment : official journal of Korean Cancer Association

10. QuickStats: Breast Cancer Death Rates Among Women Aged 50–74 Years, by Race/Ethnicity — National Vital Statistics System, United States, 2006 and 2016 Full Text available with Trip Pro

QuickStats: Breast Cancer Death Rates Among Women Aged 50–74 Years, by Race/Ethnicity — National Vital Statistics System, United States, 2006 and 2016 29851940 2018 12 12 2018 12 12 1545-861X 67 21 2018 Jun 01 MMWR. Morbidity and mortality weekly report MMWR Morb. Mortal. Wkly. Rep. QuickStats: Breast Cancer Death Rates* Among Women Aged 50-74 Years, by Race/Ethnicity - National Vital Statistics System, United States, 2006 and 2016. 614 10.15585/mmwr.mm6721a8 eng Journal Article 2018 06 01 (...) United States MMWR Morb Mortal Wkly Rep 7802429 0149-2195 2018 6 1 6 0 2018 6 1 6 0 2018 6 1 6 1 epublish 29851940 10.15585/mmwr.mm6721a8 PMC6038899

2018 Morbidity and Mortality Weekly Report

11. Burden of suicide presented as one of the leading causes of death: uncover facts or misrepresent statistics? Full Text available with Trip Pro

(EU) we used cause specific mortality statistics from the European Statistical Office (Eurostat) for the data-year 2014, and globally and for the WHO European Region we used data from Global Health Estimates (GHE) 2015. We used different sets of rules to select mutually exclusive leading underlying causes of mortality for Europe (EU28). We also present lists with estimates of leading causes of death globally, and for the WHO European Region based on the GHE 2015.In 2014, 1.2% of all reported (...) Burden of suicide presented as one of the leading causes of death: uncover facts or misrepresent statistics? Suicide is a relatively rare incident. Nevertheless, parts of the literature on intentional self-harm behaviour state that suicide is one of the leading causes of death. We aimed to assess the evidence behind the statement that suicide is a leading cause of death across all ages, with reference to the methods of ranking causes of death.Two sets of data were used: For the European Union

2018 Journal of global health

12. Changing views on child mortality and economic sanctions in Iraq: a history of lies, damned lies and statistics Full Text available with Trip Pro

Changing views on child mortality and economic sanctions in Iraq: a history of lies, damned lies and statistics In August 1990, Saddam Hussein's army invaded Kuwait and consequently the United Nations imposed economic sanctions on Iraq. In 1991, an international military alliance expelled the Iraqi army from Kuwait during a short war. Nevertheless, the economic sanctions remained in place-their removal required that Iraq should destroy its weapons of mass destruction. Subsequent years saw (...) results were used both to challenge and support the case for the invasion of Iraq in 2003. And they were cited by Tony Blair in 2010 in his testimony to the Iraq Inquiry established by the British government. Indeed, the results of the 1999 Unicef/Government of Iraq survey are still cited. Since 2003, however, several more surveys dealing with child mortality have been undertaken. Their results show no sign of a huge and enduring rise in the under-5 death rate starting in 1991. It is therefore clear

2017 BMJ global health

13. The Difference in Survival of Dental Implants Placed via Guided Surgery is Not Statistically Significant Compared to Free-Handed Placement

The Difference in Survival of Dental Implants Placed via Guided Surgery is Not Statistically Significant Compared to Free-Handed Placement UTCAT2831, Found CAT view, CRITICALLY APPRAISED TOPICs University: | | ORAL HEALTH EVIDENCE-BASED PRACTICE PROGRAM View the CAT / Title The Difference in Survival of Dental Implants Placed via Guided Surgery is Not Statistically Significant Compared to Free-Handed Placement Clinical Question In healthy patients having dental implants placed, is survival (...) greater for guided placement at 1 year postsurgery, as compared to free-handed placement? Clinical Bottom Line The survival of guided dental implants shows no definitive statistical significance at 1 year postsurgery as compared to free-handed implant placement. Best Evidence (you may view more info by clicking on the PubMed ID link) PubMed ID Author / Year Patient Group Study type (level of evidence) #1) Voulgarakis/2014 1,267 partially or fully edentulous patients in 23 included studies Systematic

2015 UTHSCSA Dental School CAT Library

14. Death Certification Errors and the Effect on Mortality Statistics Full Text available with Trip Pro

Death Certification Errors and the Effect on Mortality Statistics Errors in cause and manner of death on death certificates are common and affect families, mortality statistics, and public health research. The primary objective of this study was to characterize errors in the cause and manner of death on death certificates completed by non-Medical Examiners. A secondary objective was to determine the effects of errors on national mortality statistics.We retrospectively compared 601 death (...) errors than certificates for deaths occurring at a private residence (59% vs 39%, P < .001). A total of 580 (93%) death certificates had a change in ICD-10 codes between the original and mock certificates, of which 348 (60%) had a change in the underlying cause-of-death code.Error rates on death certificates in Vermont are high and extend to ICD-10 coding, thereby affecting national mortality statistics. Surveillance and certifier education must expand beyond local and state efforts. Simplifying

2017 Public Health Reports

15. Subcutaneous implantable cardioverter defibrillator insertion for preventing sudden cardiac death

cardioverter defibrillator insertion for preventing sudden cardiac death (IPG603) © NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 4 of 10patients with subcutaneous ICDs and patients with transvenous ICDs experienced statistically significant improvements in physical and mental quality of life between implantation and 3-month follow-up (p<0.0001) and 6-month follow-up (p<0.0001). However, the difference between 3- and 6 (...) -month follow-up was not statistically significant. 4.6 In the systematic review of 5,380 patients, the median device longevity was 5.0 years (range 4.4 to 5.6 years). 4.7 The specialist advisers listed the following key efficacy outcomes: successful detection of ventricular arrhythmias, successful delivery of shock to restore normal rhythm, prevention of sudden death and low rate of inappropriate shocks. 4.8 Seven commentaries from patients who had experience of this procedure were received, which

2018 National Institute for Health and Clinical Excellence - Interventional Procedures

16. Reliable mortality statistics in Myanmar: a qualitative assessment of challenges in two townships. Full Text available with Trip Pro

. This study identified challenges in generating reliable mortality statistics in the vital registration system of Myanmar.Qualitative methods were used to collect data in two selected townships of Mandalay Region. Grey literature related to the management of mortality registration was reviewed; in-depth interviews of sixteen key informants and fourteen focus group discussions were conducted with those involved in death registration at the local level, such as healthcare providers, local administrators (...) Reliable mortality statistics in Myanmar: a qualitative assessment of challenges in two townships. The vital registration system is universally recognized as the main source of mortality data which is essential for policy formulation, proper interventions and resource allocation to address priority health challenges. To improve availability and quality of mortality statistics by strengthening the vital registration system, understanding the current vital registration system is essential

2019 BMC Public Health

17. Producing valid statistics when legislation, culture and medical practices differ for births at or before the threshold of survival: Report of a European workshop. Full Text available with Trip Pro

Producing valid statistics when legislation, culture and medical practices differ for births at or before the threshold of survival: Report of a European workshop. Perinatal mortality is a major population health indicator providing important signals about the state of maternity care and measures of the current and future health of mothers and newborns. International comparisons are used to encourage countries to improve their perinatal health and health systems.© 2019 Royal College

2019 BJOG

18. Statistics on mortality following acute myocardial infarction in 842,897 Europeans. (Abstract)

Statistics on mortality following acute myocardial infarction in 842,897 Europeans. To compare ST-segment elevation myocardial infarction (STEMI) and non-STEMI (NSTEMI) mortality between Sweden and the UK, adjusting for background population rates of expected death, case mix and treatments.National data were collected from hospitals in Sweden (n = 73 hospitals, 180,368 patients, Swedish Web-system for Enhancement and Development of Evidence-based care in Heart disease Evaluated According (...) to Recommended Therapies [SWEDEHEART]) and the UK (n = 247, 662,529 patients, Myocardial Ischaemia National Audit Project [MINAP]) between 2003 and 2013. There were lower rates of revascularisation [STEMI (43.8% vs. 74.9%); NSTEMI (27.5% vs 43.6%)] and pharmacotherapies at time of hospital discharge including [aspirin (82.9% vs. 90.2%) and (79.9% vs. 88.0%), β-blockers (73.4% vs. 86.4%) and (65.3% vs. 85.1%)] in the UK compared with Sweden, respectively. Standardised net probability of death (NPD) between

2019 Cardiovascular Research

19. Randomized phase II/III confirmatory treatment selection design with a change of survival end points: Statistical design of Radiation Therapy Oncology Group 1216. Full Text available with Trip Pro

Randomized phase II/III confirmatory treatment selection design with a change of survival end points: Statistical design of Radiation Therapy Oncology Group 1216. To confirm the treatment effects of concurrent cetuximab plus docetaxel observed in Radiation Therapy Oncology Group (RTOG) 0234 and single out the effect of cetuximab, we designed RTOG 1216, a randomized phase II/III study, which uses an intermediate end point to select the best regimen for definitive testing of survival benefit.In (...) phase II, the best regimen should demonstrate statistically significant efficacy against the control with predefined advantage over the competing arm regarding disease-free survival (DFS). We evaluate operating characteristics of the randomized II/III group sequential design through simulations and numerical integrations under the null and various alternative hypotheses.Results show the randomized II/III design yields substantial savings on sample size and time with well-controlled type I and type

2019 Head & neck Controlled trial quality: uncertain

20. A randomized placebo-controlled trial of vitamin D supplementation for reduction of mortality and cancer: Statistical analysis plan for the D-Health Trial. Full Text available with Trip Pro

to death and cancer registries. The primary analysis for each outcome will follow an intention-to-treat approach; we will use flexible parametric survival models to investigate the association between supplementation and time to an event. We describe in detail sophisticated secondary analyses that consider non-compliance and contamination due to off-study supplementation.Publication of this statistical analysis plan in advance of the intervention's completion, and adherence to it, will avoid data (...) A randomized placebo-controlled trial of vitamin D supplementation for reduction of mortality and cancer: Statistical analysis plan for the D-Health Trial. Many observational studies have reported an association between vitamin D and non-skeletal health outcomes. The D-Health Trial was launched to determine if supplementing the older population with high monthly doses of Vitamin D can prevent cancer and premature mortality. The intervention is ongoing but here we provide a detailed statistical

2019 Contemporary clinical trials communications Controlled trial quality: predicted high

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>